chr14-65561728-A-G

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_001371533.1(FUT8):​c.165A>G​(p.Gln55Gln) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.695 in 1,612,804 control chromosomes in the GnomAD database, including 391,057 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.70 ( 37609 hom., cov: 33)
Exomes 𝑓: 0.69 ( 353448 hom. )

Consequence

FUT8
NM_001371533.1 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: 0.803

Publications

16 publications found
Variant links:
Genes affected
FUT8 (HGNC:4019): (fucosyltransferase 8) This gene encodes an enzyme belonging to the family of fucosyltransferases. The product of this gene catalyzes the transfer of fucose from GDP-fucose to N-linked type complex glycopeptides. This enzyme is distinct from other fucosyltransferases which catalyze alpha1-2, alpha1-3, and alpha1-4 fucose addition. The expression of this gene may contribute to the malignancy of cancer cells and to their invasive and metastatic capabilities. Alternative splicing results in multiple transcript variants. [provided by RefSeq, May 2011]
FUT8 Gene-Disease associations (from GenCC):
  • congenital disorder of glycosylation with defective fucosylation 1
    Inheritance: AR Classification: STRONG, MODERATE Submitted by: PanelApp Australia, Ambry Genetics, G2P, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.59).
BP6
Variant 14-65561728-A-G is Benign according to our data. Variant chr14-65561728-A-G is described in ClinVar as [Benign]. Clinvar id is 402887.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.803 with no splicing effect.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.878 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
FUT8NM_001371533.1 linkc.165A>G p.Gln55Gln synonymous_variant Exon 3 of 11 ENST00000673929.1 NP_001358462.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
FUT8ENST00000673929.1 linkc.165A>G p.Gln55Gln synonymous_variant Exon 3 of 11 NM_001371533.1 ENSP00000501213.1 Q9BYC5-1

Frequencies

GnomAD3 genomes
AF:
0.701
AC:
106415
AN:
151896
Hom.:
37565
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.731
Gnomad AMI
AF:
0.726
Gnomad AMR
AF:
0.701
Gnomad ASJ
AF:
0.692
Gnomad EAS
AF:
0.900
Gnomad SAS
AF:
0.775
Gnomad FIN
AF:
0.608
Gnomad MID
AF:
0.608
Gnomad NFE
AF:
0.677
Gnomad OTH
AF:
0.672
GnomAD2 exomes
AF:
0.705
AC:
176424
AN:
250400
AF XY:
0.704
show subpopulations
Gnomad AFR exome
AF:
0.734
Gnomad AMR exome
AF:
0.704
Gnomad ASJ exome
AF:
0.691
Gnomad EAS exome
AF:
0.902
Gnomad FIN exome
AF:
0.618
Gnomad NFE exome
AF:
0.670
Gnomad OTH exome
AF:
0.677
GnomAD4 exome
AF:
0.694
AC:
1013653
AN:
1460790
Hom.:
353448
Cov.:
48
AF XY:
0.695
AC XY:
505249
AN XY:
726710
show subpopulations
African (AFR)
AF:
0.726
AC:
24277
AN:
33428
American (AMR)
AF:
0.706
AC:
31510
AN:
44660
Ashkenazi Jewish (ASJ)
AF:
0.687
AC:
17938
AN:
26096
East Asian (EAS)
AF:
0.902
AC:
35784
AN:
39670
South Asian (SAS)
AF:
0.771
AC:
66510
AN:
86228
European-Finnish (FIN)
AF:
0.620
AC:
33115
AN:
53402
Middle Eastern (MID)
AF:
0.633
AC:
3644
AN:
5758
European-Non Finnish (NFE)
AF:
0.682
AC:
758347
AN:
1111208
Other (OTH)
AF:
0.705
AC:
42528
AN:
60340
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.474
Heterozygous variant carriers
0
15641
31281
46922
62562
78203
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
19584
39168
58752
78336
97920
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.701
AC:
106516
AN:
152014
Hom.:
37609
Cov.:
33
AF XY:
0.702
AC XY:
52161
AN XY:
74302
show subpopulations
African (AFR)
AF:
0.731
AC:
30328
AN:
41478
American (AMR)
AF:
0.701
AC:
10691
AN:
15244
Ashkenazi Jewish (ASJ)
AF:
0.692
AC:
2401
AN:
3472
East Asian (EAS)
AF:
0.900
AC:
4659
AN:
5178
South Asian (SAS)
AF:
0.774
AC:
3725
AN:
4812
European-Finnish (FIN)
AF:
0.608
AC:
6416
AN:
10544
Middle Eastern (MID)
AF:
0.602
AC:
177
AN:
294
European-Non Finnish (NFE)
AF:
0.677
AC:
46034
AN:
67972
Other (OTH)
AF:
0.675
AC:
1426
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
1641
3282
4923
6564
8205
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
832
1664
2496
3328
4160
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.685
Hom.:
58466
Bravo
AF:
0.707
Asia WGS
AF:
0.847
AC:
2943
AN:
3476
EpiCase
AF:
0.668
EpiControl
AF:
0.663

ClinVar

Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Jun 14, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
Mar 29, 2016
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency -

Congenital disorder of glycosylation with defective fucosylation 1 Benign:1
Aug 10, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

FUT8-related disorder Benign:1
May 22, 2019
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.59
CADD
Benign
7.5
DANN
Benign
0.56
PhyloP100
0.80
Mutation Taster
=98/2
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2229677; hg19: chr14-66028446; COSMIC: COSV108165620; COSMIC: COSV108165620; API